Harmonic Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Leqembi Iqlik Maintenance Treatment Launched In U.S.

08 Oct 2025

// PR NEWSWIRE

CDC Adopts ACIP Recommendations On Chickenpox, COVID-19 Vaccines

08 Oct 2025

// BIOSPACE

Former FDA official Peter Marks joins Eli Lilly

08 Oct 2025

// FIERCE BIOTECH

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

The Battery Show

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Harmonic Pharma has been founded in 2009 with a core technology dedicated to drug repurposing. The company has developed a platform to investigate the mechanism of action of any type of chemicals over the last years. Complementary AI-based solutions have been developed through the dual program entitled Chemical Range to provide public and private organizations with a more comprehensive toxicity profiling. December 2017, Seqens group announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau, President of Seqens : “The access to Harmonic Pharma’s technology broadens Seqens’ services.